why choose us

First received: June 05, 2023

Clinical Trial: Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Parkinson's Disease

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Autologous Induced Neural Stem Cell-derived Dopaminergic Precursor Cells in the Treatment of Parkinson's Disease

Brief Summary: This is a phase I, interventional, single arm, open-label, clinical study to evaluate the safety and efficacy of the striatal transplantation of autologous induced neural stem cell-derived DA precursor cells in Parkinson's Disease patients.

Read more